Jinyao Pharmaceutical (600488.SH) subsidiary obtains drug registration certificate for compound amino acid injection

Zhitong Finance APP News, Jinyao Pharmaceutical (600488.SH) announced that recently, its subsidiary Hubei Jinyao Pharmaceutical Co., Ltd. received the Drug Registration Certificate for Compound Amino Acid Injection (18AA-) approved and issued by the National Medical Products Administration. Compound Amino Acid Injection (18AA-) is used for amino acid supplementation in hypoproteinemia, malnutrition, and before and after surgery. The drug was registered and filed as a Class 4 chemical drug, and upon approval, it is deemed to have passed the consistency evaluation of generic drug quality and efficacy.